Loading stock data...

Roopa Industries Limited

BSE: ROOPAIND

BSE
47.50 0.13 (0.27%)

Prev Close

47.37

Open Price

47.41

Volume

861

Today Low / High

47.4 / 48.5

52 WK Low / High

45.11 / 86.34

Range

45 - 50

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 47.5, reflecting a change of 0.13 (0.27444%). The expected target range on the BSE is 45 - 50. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

19 Nov 48.99 0.00%
18 Nov 47.41 0.19%
17 Nov 48.01 -1.33%
14 Nov 49.99 -1.64%
13 Nov 45.11 10.82%
12 Nov 49.98 -0.20%
11 Nov 48.41 3.24%
10 Nov 50.00 -3.28%
07 Nov 51.85 -3.51%
06 Nov 49.00 3.86%
04 Nov 53.99 -7.22%
03 Nov 53.99 -5.35%
31 Oct 52.24 -1.57%
30 Oct 53.20 -1.80%
29 Oct 52.85 1.61%
28 Oct 52.44 2.02%
27 Oct 54.00 -2.89%
24 Oct 54.00 0.00%
23 Oct 54.00 0.00%

Roopa Industries Limited Graph

Roopa Industries Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Roopa Industries Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 47.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 47.50 47.98 43.18 - 52.77
48.45 38.76 - 58.14
48.93 34.25 - 63.60
Bearish Scenario 47.50 47.03 42.32 - 51.73
46.55 37.24 - 55.86
46.08 32.25 - 59.90

Overview of Roopa Industries Limited

ISIN

INE443C01010

Industry

Medical - Pharmaceuticals

Vol.Avg

1,576

Market Cap

385,331,825

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

-131.44

DCF

198

Financial Ratios Every Investor Needs

Stock Rating Details for ROOPAIND

Metric Value Recommendation
Overall Rating B Neutral
DCF Score 5 Strong Buy
ROE Score 4 Buy
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 3 Neutral

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 120.69 Cr 113.85 Cr 6.84 Cr 0.0567 0.00 Cr 0.00 Cr 3.26 Cr 2.03 Cr 2.57 6.41 Cr 0.0169
2024-03-31 71.55 Cr 64.26 Cr 7.30 Cr 0.1020 0.00 Cr 0.39 Cr 4.81 Cr 1.52 Cr 1.95 5.57 Cr 0.0212
2023-03-31 75.89 Cr 61.99 Cr 13.90 Cr 0.1832 0.00 Cr 0.30 Cr 3.39 Cr 1.35 Cr 1.72 4.54 Cr 0.0178
2022-03-31 51.21 Cr 40.32 Cr 10.89 Cr 0.2127 0.00 Cr 0.29 Cr 2.58 Cr 1.02 Cr 1.29 3.50 Cr 0.0198
2021-03-31 28.61 Cr 17.68 Cr 10.77 Cr 0.3762 0.00 Cr 0.27 Cr 7.07 Cr 0.72 Cr 0.91 2.62 Cr 0.0250

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 3.38 Cr 76.46 Cr 58.96 Cr 17.4944 Cr 33.27 Cr 28.65 Cr 36.15 Cr 8.81 Cr 0.00 Cr 0.00 Cr 0.02 Cr 50.7512 Cr
2024-03-31 2.98 Cr 64.68 Cr 49.21 Cr 15.4734 Cr 25.75 Cr 22.77 Cr 25.16 Cr 9.62 Cr 0.00 Cr 0.00 Cr 0.02 Cr 42.5601 Cr
2023-03-31 1.95 Cr 56.55 Cr 42.61 Cr 13.9430 Cr 18.87 Cr 16.93 Cr 18.38 Cr 10.86 Cr 0.67 Cr 0.45 Cr 0.01 Cr 39.2407 Cr
2022-03-31 1.49 Cr 49.02 Cr 36.44 Cr 12.5844 Cr 11.97 Cr 10.48 Cr 15.34 Cr 10.38 Cr 0.62 Cr 0.00 Cr 0.01 Cr 31.0305 Cr
2021-03-31 0.50 Cr 46.33 Cr 34.77 Cr 11.5646 Cr 13.46 Cr 12.96 Cr 19.46 Cr 10.46 Cr 0.27 Cr 0.00 Cr 0.35 Cr 25.6097 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -13.1183 Cr -0.0577 Cr 13.5803 Cr -13.9706 Cr 1.6443 Cr 4.6219 Cr -0.8523 Cr 2.0349 Cr 7.6737 Cr 0.0000 Cr -10.9849 Cr
2024-03-31 -3.2847 Cr 1.1131 Cr 3.2041 Cr 3.8279 Cr 1.0325 Cr 3.0841 Cr 0.0000 Cr 1.5191 Cr 4.0273 Cr 0.0000 Cr -6.7856 Cr
2023-03-31 8.9114 Cr -0.9874 Cr -7.4707 Cr 7.5400 Cr 0.4533 Cr 1.9452 Cr -1.3714 Cr 1.8067 Cr -5.9921 Cr 0.0000 Cr -3.0370 Cr
2022-03-31 2.3445 Cr 3.6533 Cr -5.0075 Cr 1.5019 Cr 0.9903 Cr 1.4919 Cr -0.8426 Cr 1.3603 Cr -3.7242 Cr 0.0000 Cr 4.1158 Cr
2021-03-31 -0.5151 Cr 1.3369 Cr -0.5754 Cr -1.2572 Cr 0.2464 Cr 0.5016 Cr -0.7421 Cr 0.9325 Cr 0.2185 Cr 0.0000 Cr -7.1045 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 35.07 Cr 31.95 Cr 3.12 Cr 0.0889 1.21 Cr 0.28 Cr 0.36 1.43 Cr 0.0081
2025-03-31 29.83 Cr 28.72 Cr 1.11 Cr 0.0372 0.25 Cr 0.42 Cr 0.53 1.58 Cr 0.0140
2024-12-31 30.73 Cr 28.05 Cr 2.68 Cr 0.0872 0.71 Cr 0.76 Cr 0.97 1.89 Cr 0.0247
2024-09-30 25.61 Cr 22.32 Cr 3.29 Cr 0.1286 1.44 Cr 0.58 Cr 0.74 1.64 Cr 0.0228
2024-06-30 34.51 Cr 32.52 Cr 1.99 Cr 0.0576 0.85 Cr 0.27 Cr 0.35 1.29 Cr 0.0079

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 4.62 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -17.49 Cr
2025-03-31 4.62 Cr 0.00 Cr 4.62 Cr 13.00 Cr 36.15 Cr 67.28 Cr 8.81 Cr 76.46 Cr 58.96 Cr
2024-12-31 0.00 Cr 0.00 Cr 4.82 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -16.33 Cr
2024-09-30 3.66 Cr 1.17 Cr 4.82 Cr 2.22 Cr 23.93 Cr 59.58 Cr 9.05 Cr 76.86 Cr 60.53 Cr
2024-06-30 0.00 Cr 0.00 Cr 4.25 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -15.47 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.28 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.42 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.76 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.58 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.27 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹789.20 ₹94,520,665,683.00 ₹9,385.00

Key Executives

Whole Time Executive Director
Mr. Vaduguri Joginatha Sarma

Gender: male

Year Born: 1956

Company Secretary & Compliance Officer
Ms. Indani Venkata Lakshmi

Gender: female

Year Born:

Executive Chairman & MD
Mr. Tumbalam Gooty Raghavendra

Gender: male

Year Born: 1954

Chief Financial Officer
Mr. Bheemaneni Vishnu Vardhan

Gender: male

Year Born:

FAQs about Roopa Industries Limited

Who is the CEO of the company?

The CEO is Tumbalam Gooty Raghavendra.

What is the current market price of the stock?

The current price is ₹48.99.

What is the 52-week price range?

The range is ₹45.11-86.34.

What is the market capitalization of the company?

The market capitalization is ₹38.53 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 18.86.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Roopa Industries Limited (ISIN: INE443C01010) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹38.53 crores and an average daily volume of 1,576 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.